🇺🇸 FDA

Drug profile · INN

metformin hydrochloride, sitagliptin phosphate

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

metformin hydrochloride, sitagliptin phosphate (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: film coated. Current US regulatory status: approved.

Key facts

INN metformin hydrochloride, sitagliptin phosphate
Brand SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
Route FILM COATED
Formulation TABLET

Frequently asked questions

What is metformin hydrochloride, sitagliptin phosphate?

metformin hydrochloride, sitagliptin phosphate (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: film coated. Current US regulatory status: approved.

What is the brand name for metformin hydrochloride, sitagliptin phosphate?

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE is a marketed brand name for metformin hydrochloride, sitagliptin phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of metformin hydrochloride, sitagliptin phosphate?

metformin hydrochloride, sitagliptin phosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.